Cash Flow Statement

Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Non-cash Items Other financing activities Preferred Shares Issued Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Crinetics Pharmaceuticals (CRNX) Amortization of Deferred Charges (2019)

Historic Amortization of Deferred Charges for Crinetics Pharmaceuticals (CRNX) over the last 1 years, with Q1 2019 value amounting to $53000.0.